Status:
COMPLETED
Photodynamic Therapy in Occult-Only Lesions (POOL)
Lead Sponsor:
Novartis
Collaborating Sponsors:
QLT Inc.
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Age related macular degeneration is the leading cause of blindness for people over 50 in the western world. Blood vessels which start to grow form a lesion in the back of the eye. Verteporfin may stab...
Eligibility Criteria
Inclusion
- 50 years or older
- Must see better or equal to 34 letters (visual acuity)
- Choroidal neovascularization (CNV) lesion must be occult only
Exclusion
- Evidence of classic CNV in the lesion
- Prior treatment of disease in study eye
- Have a history of moderate to severe hepatic impairment
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00135837
Start Date
June 1 2003
Last Update
June 21 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Basel, Switzerland